(Q33327591)

25 July 2017

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent (English)

1 reference

25 July 2017

1 reference

1 reference

Anne-Marie Mes-Masson

object named as

Anne-Marie Mes-Masson

5

0 references

author name string

Luca Cavallone

1

1 reference

25 July 2017

Suzanna L Arcand

2

1 reference

25 July 2017

Christine Maugard

3

1 reference

25 July 2017

Parviz Ghadirian

4

1 reference

25 July 2017

Diane Provencher

6

1 reference

25 July 2017

Patricia N Tonin

7

1 reference

25 July 2017

language of work or name

English

0 references

publication date

10 April 2008

1 reference

25 July 2017

1 reference

25 July 2017

8

1 reference

25 July 2017

96

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-96

25 July 2017

0 references

cites work

Modifiers of risk of hereditary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Haplotype analysis suggest common founders in carriers of the recurrent BRCA2mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Population history and its impact on medical genetics in Quebec

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Human genetics: lessons from Quebec populations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

dbSNP: the NCBI database of genetic variation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Two polymorphic variants of wild-type p53 differ biochemically and biologically

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

A Monte Carlo method for combined segregation and linkage analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

p53 polymorphisms and haplotypes in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Evidence against involvement of p53 polymorphism in breast cancer predisposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

The R72P P53 mutation is associated with familial breast cancer in Jewish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

P53 codon 72 polymorphism in breast cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5BRCA1 andBRCA2 mutations

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Haplotype Analysis of BRCA2 8765delAG Mutation Carriers in French Canadian and Yemenite Jewish Hereditary Breast Cancer Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

p53 Mutations, Polymorphisms, and Haplotypes in Pakistani Ethnic Groups and Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-96

Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2329651

p53 germline polymorphisms are associated with an increased risk for breast cancer in German women

31 October 2018

1 reference

12 December 2020

Breast cancer risk inBRCA1 andBRCA2 mutation carriers and polyglutamine repeat length in theAIB1 gene

1 reference

12 December 2020

A haplotype containing thep53polymorphisms Ins16bp and Arg72Pro modifies cancer risk inBRCA2mutation carriers

1 reference

12 December 2020

p53 codon 72 polymorphism as a risk factor in the development of breast cancer

1 reference

12 December 2020

Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years

1 reference

12 December 2020

Polygenic inheritance of breast cancer: Implications for design of association studies

1 reference

12 December 2020

p53 polymorphism in ovarian and breast cancer

1 reference

12 December 2020

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-96

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference